The store will not work correctly when cookies are disabled.
(E)-2-(1H-Benzoimidazol-2-yl)-3-(5-chloro-thiophen-2-yl)-acrylonitrile
ID: ALA331840
PubChem CID: 5940522
Max Phase: Preclinical
Molecular Formula: C14H8ClN3S
Molecular Weight: 285.76
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: N#C/C(=C\c1ccc(Cl)s1)c1nc2ccccc2[nH]1
Standard InChI: InChI=1S/C14H8ClN3S/c15-13-6-5-10(19-13)7-9(8-16)14-17-11-3-1-2-4-12(11)18-14/h1-7H,(H,17,18)/b9-7+
Standard InChI Key: AMSKJZMMLLKMSN-VQHVLOKHSA-N
Molfile:
RDKit 2D
19 21 0 0 0 0 0 0 0 0999 V2000
0.6875 -1.4500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2042 -0.7875 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.5125 -1.4417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2042 -2.1250 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.9250 -2.1542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7500 -2.1542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3667 -2.7042 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.0792 -2.2875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5833 -1.0417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9250 -0.7292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5833 -1.8667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3417 -0.0125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9042 -1.4792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0792 -1.3917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7875 -2.7042 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-1.2958 -0.6292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2958 -2.2792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0083 -1.8667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0083 -1.0417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 1 1 0
4 1 1 0
5 3 2 0
6 5 1 0
7 6 1 0
8 7 1 0
9 2 1 0
10 3 1 0
11 4 1 0
12 10 3 0
13 14 1 0
14 6 2 0
15 8 1 0
16 9 1 0
17 11 1 0
18 17 2 0
19 16 2 0
11 9 2 0
19 18 1 0
8 13 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 285.76 | Molecular Weight (Monoisotopic): 285.0127 | AlogP: 4.34 | #Rotatable Bonds: 2 |
Polar Surface Area: 52.47 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.51 | CX Basic pKa: 3.62 | CX LogP: 4.38 | CX LogD: 4.38 |
Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.71 | Np Likeness Score: -2.17 |
References
1. Saczewski F, Reszka P, Gdaniec M, Grünert R, Bednarski PJ.. (2004) Synthesis, X-ray crystal structures, stabilities, and in vitro cytotoxic activities of new heteroarylacrylonitriles., 47 (13): [PMID:15189040] [10.1021/jm0311036] |